Author

July Xi Chen

Chinese University of Hong Kong

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

Alex Chun Ho Law· 2 shared Allen Ming Fai Leung· 2 shared Carol Lee· 2 shared Cherie Tsz‐Yiu Law· 2 shared Mary Po Ki Chau· 2 shared Sai Fung YeungiD· 2 shared Stephen Kwok‐Wing TsuiiD· 2 shared William C. ChoiD· 2 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Alex Chun Ho Law

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A mutation-resolved therapeutic atlas of NRAS-mutant melanoma reveals genotype-selective response to RAS(ON) inhibition and adaptive STAT3 survival

Sai Fung Yeung, July Xi Chen, Cherie Tsz‐Yiu Law, Alex Chun Ho Law, Carol Lee, Allen Ming Fai Leung, Mary Po Ki Chau, Ben Ko Chi-Bun, Wu Yue, Man Tong, 梁开喜, William C. Cho, Michelle K.Y. Siu, Karen Kar Loen Chan, Chunning Leung, Stephen Kwok‐Wing Tsui

This paper identifies genotype-specific responses to RAS(ON) inhibitors in NRAS-mutant melanoma and shows that STAT3 inhibition enhances therapeutic efficacy.

bioRxiv · Mar 13, 2026 · PreprintCancer Biology

Functional and sensitivity profiling of theKITMutation Landscape in Melanoma

Sai Fung Yeung, Mandy Sze Man Chan, Cherie Tsz‐Yiu Law, Alex Chun Ho Law, Carol Lee, Allen Ming Fai Leung, Mary Po Ki Chau, Helen Hoi Yin Chan, July Xi Chen, Ben C.B. Ko, Karen K.L. Chan, William C. Cho, Stephen Kwok‐Wing Tsui

This study identifies KIT mutation hotspots in Asian melanoma and evaluates drug sensitivities, showing that some mutations are resistant to imatinib but responsive to other inhibitors.

bioRxiv · Feb 20, 2026 · PreprintCancer Biology